232 related articles for article (PubMed ID: 16826476)
1. Leishmania donovani infection of human myeloid dendritic cells leads to a Th1 response in CD4+ T cells from healthy donors and patients with kala-azar.
Ghosh M; Mandal L; Maitra S; Rakshit S; Paul K; Bagchi J; Ganguly D; Pal C; Bandyopadhyay S
J Infect Dis; 2006 Aug; 194(3):294-301. PubMed ID: 16826476
[TBL] [Abstract][Full Text] [Related]
2. Human dendritic cell (DC)-based anti-infective therapy: engineering DCs to secrete functional IFN-gamma and IL-12.
Ahuja SS; Mummidi S; Malech HL; Ahuja SK
J Immunol; 1998 Jul; 161(2):868-76. PubMed ID: 9670965
[TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis.
Bimal S; Singh SK; Sinha S; Pandey K; Sinha PK; Ranjan A; Bhattacharya SK; Das P
Exp Parasitol; 2008 Feb; 118(2):238-46. PubMed ID: 17904553
[TBL] [Abstract][Full Text] [Related]
4. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
[TBL] [Abstract][Full Text] [Related]
5. Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10-producing CD4+ T cells.
Rea D; Laface D; Hutchins B; Kwappenberg K; Melief CJ; Hoeben RC; Offringa R
Hum Immunol; 2004 Nov; 65(11):1344-55. PubMed ID: 15556685
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation.
Prina E; Abdi SZ; Lebastard M; Perret E; Winter N; Antoine JC
J Cell Sci; 2004 Jan; 117(Pt 2):315-25. PubMed ID: 14657281
[TBL] [Abstract][Full Text] [Related]
7. CD40 expression levels modulate regulatory T cells in Leishmania donovani infection.
Martin S; Agarwal R; Murugaiyan G; Saha B
J Immunol; 2010 Jul; 185(1):551-9. PubMed ID: 20525887
[TBL] [Abstract][Full Text] [Related]
8. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells.
Lee JS; Lee JC; Lee CM; Jung ID; Jeong YI; Seong EY; Chung HY; Park YM
Biochem Pharmacol; 2007 Jun; 74(1):86-97. PubMed ID: 17482145
[TBL] [Abstract][Full Text] [Related]
10. Identification of amastigote-specific antigens of Leishmania donovani using kala-azar patient sera.
Gupta N; Goyal N; Bhatia N; Kamboj KK; Rastogi AK
Indian J Exp Biol; 2001 Jul; 39(7):623-8. PubMed ID: 12019753
[TBL] [Abstract][Full Text] [Related]
11. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
[TBL] [Abstract][Full Text] [Related]
12. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells.
Silverman JM; Clos J; Horakova E; Wang AY; Wiesgigl M; Kelly I; Lynn MA; McMaster WR; Foster LJ; Levings MK; Reiner NE
J Immunol; 2010 Nov; 185(9):5011-22. PubMed ID: 20881185
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the immunomodulatory effects of L. donovani and L. major excreted-secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cells.
Revest M; Donaghy L; Cabillic F; Guiguen C; Gangneux JP
Vaccine; 2008 Nov; 26(48):6119-23. PubMed ID: 18804505
[TBL] [Abstract][Full Text] [Related]
14. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection.
Kanto T; Inoue M; Miyatake H; Sato A; Sakakibara M; Yakushijin T; Oki C; Itose I; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Infect Dis; 2004 Dec; 190(11):1919-26. PubMed ID: 15529255
[TBL] [Abstract][Full Text] [Related]
15. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis.
Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A
J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458
[TBL] [Abstract][Full Text] [Related]
16. Maturation of circulating dendritic cells and imbalance of T-cell subsets in patients with squamous cell carcinoma of the head and neck.
Sakakura K; Chikamatsu K; Takahashi K; Whiteside TL; Furuya N
Cancer Immunol Immunother; 2006 Feb; 55(2):151-9. PubMed ID: 15889251
[TBL] [Abstract][Full Text] [Related]
17. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
18. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
19. Ambient particulate matter directs nonclassic dendritic cell activation and a mixed TH1/TH2-like cytokine response by naive CD4+ T cells.
Williams MA; Porter M; Horton M; Guo J; Roman J; Williams D; Breysse P; Georas SN
J Allergy Clin Immunol; 2007 Feb; 119(2):488-97. PubMed ID: 17187851
[TBL] [Abstract][Full Text] [Related]
20. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
